Science recap: This week's discoveries include new clues from the fossil skull of a mysterious human species
Tens of thousands of years ago, our species — Homo sapiens — mingled and interbred with other prehistoric humans: our distant cousins, the Neanderthals and Denisovans.
Hundreds of Neanderthal fossils give us a good idea of their appearance, lives and relationships, but so little is known about Denisovans that they still don't have an official scientific name.
Evidence of their existence has surfaced in faint traces, mapped by DNA markers that lurk in our own genetic makeup and confirmed by only a few fossil fragments.
This week, however, a 146,000-year-old skull dredged out of a well in China in 2018 may just be a key missing piece to this cryptic evolutionary puzzle.
The nearly complete skull did not match any previously known species of prehistoric human.
But two new studies — which researchers say are among the biggest paleoanthropology papers of the year — detail how scientists were able to extract genetic material from the fossil and help unravel this biological mystery.
The DNA sample taken from 'Dragon Man,' as the specimen is called, revealed that he was in fact related to Denisovans, early humans who are thought to have lived between roughly 500,000 and 30,000 years ago.
The finding could be monumental, helping to paint a fuller picture of a time when our own species coexisted with other prehistoric humans.
Astronomers have long grappled with the quandary of 'dark matter,' but plenty of enigmas surround regular matter as well.
The proton-and-neutron-based atoms that we're familiar with are called baryonic matter. And this material is strewn between galaxies like intergalactic fog, making it extremely difficult to measure.
Perhaps, that is, until now.
A new study explains how scientists were able to observe the baryonic matter using the flashing of fast radio bursts.
In a rare encounter, scientists have captured the first-ever footage of an elusive 3-foot-long squid alive in its deep-sea habitat.
Fruit, flowers, birds and musical instruments decorated the walls of a luxury villa — part of a site the excavation team dubbed the 'Beverly Hills' of Roman Britain — before the building was razed roughly 1,800 years ago.
The frescoes were painstakingly pieced together by experts from the Museum of London Archaeology. Han Li, senior building material specialist at MOLA, described the effort as a 'once in a lifetime' opportunity.
Romans invaded modern-day Britain in AD 43 and established Londinium, the precursor to modern London. The occupation lasted for almost 400 years.
Under the life-affirming glow of the sun, methane is a dangerous gas to be avoided.
A heat-trapping chemical pollutant in Earth's atmosphere, methane exacerbates the climate crisis. But within the planet's deep recesses — thousands of feet below the ocean's surface off the US West Coast — the gas can be transformed into a nutritious meal.
At least for spiders.
Scientists say they've discovered three previously unknown species of sea spider living around methane seeps. In these marine habitats where sunlight can't reach, gas escapes through cracks in the seafloor and feeds bacteria that latch on to the spiders' exoskeletons.
The bacteria convert carbon-rich methane and oxygen into sugars and fats the spiders can eat, according to a new study.
The newfound Sericosura sea spiders may pass methane-fueled bacteria to their hatchlings as an easy source of food, the researchers suggest.
Check out these other must-read science stories from the week:
— A SpaceX Starship rocket exploded during a routine ground test on Wednesday. Explore how this and other recent setbacks may affect the company's Mars ambitions.
— A tiny brown moth in Australia migrates some 600 miles at night using the stars for navigation — something only humans and birds were known to do before.
— A hunt for ghostly cosmic particles found anomalous signals coming from Antarctic ice. A new detector could help scientists explain what they are.
— Researchers used DNA to reconstruct the face of a prehistoric woman who lived around 10,500 years ago in what's now Belgium, suggesting that skin color already varied considerably among different populations.
Like what you've read? Oh, but there's more. Sign up here to receive in your inbox the next edition of Wonder Theory, brought to you by CNN Space and Science writers Ashley Strickland, Katie Hunt and Jackie Wattles. They find wonder in planets beyond our solar system and discoveries from the ancient world.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
4 hours ago
- Medscape
Erectile Function After Prostate Radiation: How MRI May Help
TOPLINE: Among patients with prostate cancer who received MRI-guided stereotactic body radiation therapy (SABR), more than 80% demonstrated 'classic' neurovascular bundle patterns and over 96% showed more than 1-cm separation of internal pudendal arteries from the prostate. These findings indicated that most patients have favorable anatomic patterns that would allow radiation oncologists to minimize radiation to structures involved in erectile function and help reduce patients' risk for posttreatment erectile dysfunction. METHODOLOGY: Erectile dysfunction is a common side effect for men with prostate cancer who undergo SABR. Radiation-related damage to critical nearby structures, such as the neurovascular bundles and internal pudendal arteries, likely contributes to this issue. Identifying these structures on MRI during radiation planning can minimize exposure during SABR and reduce the risk for erectile dysfunction. Researchers analyzed 160 consecutive patients with prostate cancer (median age, 70 years) who underwent MRI-linear accelerator-based SABR between January and December 2024. Based on the MRI scans, researchers classified neurovascular bundle patterns into classic (discrete), adherent (dispersed and adherent to the prostatic capsule), or absent. Researchers also measured the shortest distance between internal pudendal arteries to the prostate capsule and the membranous urethral length and compared imaging features by prostate volumes, Prostate Imaging Reporting and Data System (PI-RADS) scores, lesion locations, and Gleason grade group. TAKEAWAY: The classic neurovascular bundle pattern was the most common, present in 80% of right-sided and 85% of left-sided evaluations, while adherent neurovascular bundles were less common, observed in 18.1% of right-sided and 13.8% of left-sided scans. The median shortest distance between internal pudendal arteries and the prostate capsule was 2.3 cm on both sides, with only 3.1% (left side) to 3.8% (right side) of patients having a distance less than 1.0 cm. The median membranous urethral length was 1.5 cm, with only 2.5% of men having one shorter than 1.0 cm. Researchers found no significant association between these MRI features and prostate volumes of greater or less than 40 mL, PI-RADS scores, zonal location of the dominant intraprostatic lesion, and Gleason grade on pathology. IN PRACTICE: 'Most patients with prostate cancer undergoing SABR demonstrated favorable anatomy of the critical structures, potentially important for potency preservation,' the authors wrote, reflecting on the fact that real-time adaptive planning, especially with MRI-guided radiotherapy, has potential for helping 'identify, define, and effectively dose-constrain these critical structures.' SOURCE: The study, led by Sungmin Woo, MD, PhD, NYU Grossman School of Medicine in New York City, was published online in Practical Radiation Oncology. LIMITATIONS: The study was conducted at a single institution, which may limit the generalizability of the findings. Additionally, the analysis excluded patients with prior prostate-directed treatments, artifacts on MRI scans, and extraprostatic extension or those without diagnostic multiparametric MRI scans, restricting applicability to patients with more advanced disease or suboptimal imaging. DISCLOSURES: This study did not receive any specific funding. One author disclosed serving as a consultant for Boston Scientific. The other authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.


Fast Company
7 hours ago
- Fast Company
NASA is putting a nuclear reactor on the moon. It could reshape space governance
The first space race was about flags and footprints. Now, decades later, landing on the moon is old news. The new race is to build there, and doing so hinges on power. In April 2025, China reportedly unveiled plans to build a nuclear power plant on the moon by 2035. This plant would support its planned international lunar research station. The United States countered in August, when acting NASA Administrator Sean Duffy reportedly suggested a U.S. reactor would be operational on the moon by 2030. While it might feel like a sudden sprint, this isn't exactly breaking news. NASA and the Department of Energy have spent years quietly developing small nuclear power systems to power lunar bases, mining operations, and long-term habitats. As a space lawyer focused on long-term human advancement into space, I see this not as an arms race but as a strategic infrastructure race. And in this case, infrastructure is influence. A lunar nuclear reactor may sound dramatic, but it's neither illegal nor unprecedented. If deployed responsibly, it could allow countries to peacefully explore the moon, fuel their economic growth, and test out technologies for deeper space missions. But building a reactor also raises critical questions about access and power. The legal framework already exists Nuclear power in space radioisotope generators that use small amounts of radioactive elements—a type of nuclear fuel— to power satellites, Mars rovers, and the Voyager probes. The United Nations' 1992 Principles Relevant to the Use of Nuclear Power Sources in Outer Space, a nonbinding resolution, recognizes that nuclear energy may be essential for missions where solar power is insufficient. This resolution sets guidelines for safety, transparency, and international consultation. Nothing in international law prohibits the peaceful use of nuclear power on the moon. But what matters is how countries deploy it. And the first country to succeed could shape the norms for expectations, behaviors, and legal interpretations related to lunar presence and influence. Why being first matters The 1967 Outer Space Treaty, ratified by all major spacefaring nations including the U.S., China, and Russia, governs space activity. Its Article IX requires that states act with 'due regard to the corresponding interests of all other States Parties.' That statement means if one country places a nuclear reactor on the moon, others must navigate around it, legally and physically. In effect, it draws a line on the lunar map. If the reactor anchors a larger, long-term facility, it could quietly shape what countries do and how their moves are interpreted legally, on the moon and beyond. Other articles in the Outer Space Treaty set similar boundaries on behavior, even as they encourage cooperation. They affirm that all countries have the right to freely explore and access the moon and other celestial bodies, but they explicitly prohibit territorial claims or assertions of sovereignty. At the same time, the treaty acknowledges that countries may establish installations such as bases—and with that, gain the power to limit access. While visits by other countries are encouraged as a transparency measure, they must be preceded by prior consultations. Effectively, this grants operators a degree of control over who can enter and when. Building infrastructure is not staking a territorial claim. No one can own the moon, but one country setting up a reactor could shape where and how others operate—functionally, if not legally. Infrastructure is influence where ice found in perpetually shadowed craters could fuel rockets and sustain lunar bases. These sought-after regions are scientifically vital and geopolitically sensitive, as multiple countries want to build bases or conduct research there. Building infrastructure in these areas would cement a country's ability to access the resources there and potentially exclude others from doing the same. Critics may worry about radiation risks. Even if designed for peaceful use and contained properly, reactors introduce new environmental and operational hazards, particularly in a dangerous setting such as space. But the U.N. guidelines do outline rigorous safety protocols, and following them could potentially mitigate these concerns. Why nuclear? Because solar has limits The moon has little atmosphere and experiences 14-day stretches of darkness. In some shadowed craters, where ice is likely to be found, sunlight never reaches the surface at all. These issues make solar energy unreliable, if not impossible, in some of the most critical regions. A small lunar reactor could operate continuously for a decade or more, powering habitats, rovers, 3D printers, and life-support systems. Nuclear power could be the linchpin for long-term human activity. And it's not just about the Moon—developing this capability is essential for missions to Mars, where solar power is even more constrained. A call for governance, not alarm The United States has an opportunity to lead not just in technology but in governance. If it commits to sharing its plans publicly, following Article IX of the Outer Space Treaty and reaffirming a commitment to peaceful use and international participation, it will encourage other countries to do the same. The future of the moon won't be determined by who plants the most flags. It will be determined by who builds what, and how. Nuclear power may be essential for that future. Building transparently and in line with international guidelines would allow countries to more safely realize that future. A reactor on the moon isn't a territorial claim or a declaration of war. But it is infrastructure. And infrastructure will be how countries display power—of all kinds—in the next era of space exploration. Michelle L.D. Hanlon is a professor of air and space law at the University of Mississippi. The early-rate deadline for Fast Company's Most Innovative Companies Awards is Friday, September 5, at 11:59 p.m. PT. Apply today.


Medscape
11 hours ago
- Medscape
Clozapine May Up Infection Risk in Schizophrenia
TOPLINE: Clozapine use was associated with a 25% higher risk for infections in patients with schizophrenia than the use of olanzapine, with a 45% higher risk in those aged 55 years or older, a large cohort study showed. METHODOLOGY: The population-based cohort study included electronic health record data from the Hong Kong Hospital Authority for more than 11,051 adults with schizophrenia. Participants had used clozapine (n = 1450; mean age, 41 years; 52% women) or olanzapine (n = 9601; mean age, 45 years; 55% women) continuously for 90 or more days and had previously used at least two other antipsychotic medications, representing a cohort with treatment resistance. The primary outcome was occurrence of any infectious disease, with subtypes analyzed as secondary outcomes. Medication was initiated from 2004 to 2023, with 2002-2003 as a wash-out period. Mean follow-up periods for clozapine and olanzapine users were about 6.9 years and 5 years, respectively. TAKEAWAY: Overall, 3551 cases of infections were observed during the study. Clozapine use was associated with a significantly greater risk for infection than olanzapine use (weighted hazard ratio [HR], 1.25; P < .0001). Risk for infection from use of clozapine vs olanzapine increased with age: 18-44 years (weighted HR, 1.24; P = .002), 44-54 years (weighted HR, 1.41; P = .001), and 55 years or older (weighted HR, 1.45; P = .002). Risk for upper and lower respiratory tract infections was also significantly higher with use of clozapine vs olanzapine (weighted HRs, 1.50 and 1.71, respectively; P < .0001 for both) as was the risk for gastrointestinal infections (weighted HR, 1.90; P = .0001). Although men and women both had significantly greater infection risk with use of clozapine vs olanzapine, the rate was greater in men (weighted HRs, 1.32 and 1.18, respectively). IN PRACTICE: The investigators noted that although there have been calls to relax current requirements for regular hematological monitoring when using clozapine, their findings 'underscore the importance of regular follow-up to identify early and manage infections, which possibly arise because of a weakened immune system.' Authors of an accompanying editorial noted that patients receiving higher doses might be at even greater risk for adverse events. 'An intermediate balance of personalized dosing designed to limit clozapine-induced inflammation and regular blood testing and physical monitoring…could offer a safe and less invasive compromise to maximize the number of patients receiving clozapine treatment,' the editorial authors wrote. SOURCE: The study was led by Yuqi Hu, the University of Hong Kong, Hong Kong. The editorial was led by Scott R. Clark, University of Adelaide, Adelaide, Australia. Both were published online on July 28 in The Lancet Psychiatry. LIMITATIONS: The study was limited by its observational design, which may have introduced selection bias, and by the absence of key covariates, including socioeconomic status and lifestyle factors. It also lacked laboratory data on drug levels and immune function and only captured infections requiring secondary or tertiary care. Additional constraints included unmeasured anticholinergic effects, a predominantly Chinese cohort that limited generalizability, and not including patients with lived experience. DISCLOSURES: The study was partially supported by the Laboratory of Data Discovery for Health funded by AIR@InnoHK. Some of the study investigators and editorialists reported having financial, advisory, or employment ties with various sources, including pharmaceutical companies. Full details are provided in the original articles. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.